China Vaccine Market Analyzed in New CRI Report Recently Published at MarketPublishers.com09 Mar 2012 • by Natalie Aster
LONDON – Due to the low per capital income and the lack of medical guarantee, the market scale of Chinese vaccine is relatively small. Thus, last year’s scale of the vaccine market in China was about CNY 15 billion, while the scale of pharmaceutical industry was about CNY 1.45 trillion in the same period. The sales revenue of the country’s vaccine industry was only about 1% of that of the pharmaceutical industry and it accounted for less than 3% of the global revenue in the same period. As is evident, there is still much space for growth.
However, driven by many factors, China’s vaccine market is expected to maintain a rapid development going forward, though the competition looks like to be fiercer. Parts of less competitive enterprises will run upon the rocks or be merged and reorganized, and the vaccine market concentration rate will keep on increasing.
Most recent “Research Report on Chinese Human Vaccine Industry, 2012” drawn up by China Research and Intelligence (CRI) has been recently published by Market Publishers Ltd.
Research Report on Chinese Human Vaccine Industry, 2012
Published: March, 2012
Price: US$ 3.000,00
The research report draws up an elaborate picture of China’s vaccine market.
- analysis of global and Chinese vaccine industry;
- government policy of vaccine industry in China;
- competition in China’s vaccine market;
- major vaccine of Chinese market;
- development trend of Chinese vaccine market;
- operation of China's major vaccine manufacturers.
More new market research reports by the publisher can be found at CRI page.